Dimensional Fund Advisors’s Lantern Pharma LTRN Stock Holding History

Dimensional Fund Advisors’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-16,725	Closed	-$69.7K	–	3262
2026 Q2	$69.7K	Sell	16,725 -21,335	-56%	-$62.5K	﹤0.01%	3167
2026 Q1	$52.1K	Sell	38,060 -1,050	-3%	-$2.94K	﹤0.01%	3175
2025 Q4	$119K	Sell	39,110 -1,034	-3%	-$3.85K	﹤0.01%	3137
2025 Q3	$175K	Sell	40,144 -796	-2%	-$3.32K	﹤0.01%	3134
2025 Q2	$129K	Buy	40,940 +3,457	+9%	+$11.7K	﹤0.01%	3162
2025 Q1	$133K	Buy	37,483 +934	+3%	+$3.88K	﹤0.01%	3170
2024 Q4	$117K	Sell	36,549 -999	-3%	-$3.42K	﹤0.01%	3228
2024 Q3	$138K	Buy	37,548 +19,135	+104%	+$78.8K	﹤0.01%	3215
2024 Q2	$86K	Buy	18,413 +6,585	+56%	+$39.6K	﹤0.01%	3267
2024 Q1	$104K	Hold	11,828	–	–	﹤0.01%	3257
2023 Q4	$50.6K	Buy	+11,828	New	+$41.7K	﹤0.01%	3345

Other funds holding LTRN

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Entrust Financial Wayne, Pennsylvania $205M AUM 12.8% 1-Year Est. Return

Key Financial Inc West Chester, Pennsylvania $614M AUM 14.43% 1-Year Est. Return

Dimensional Fund Advisors's LTRN Position: Q3 2026 in Review

Dimensional Fund Advisors sold out of Lantern Pharma (LTRN) in Q3 2026, closing a stake of 16,725 shares — an estimated $69.7K sold.

Dimensional Fund Advisors first reported a position in LTRN in Q4 2023 and held it in 11 quarters. The position peaked at $175K in Q3 2025. 8 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

Dimensional Fund Advisors reported no remaining Lantern Pharma position as of Q3 2026 after selling out during the quarter.
Dimensional Fund Advisors sold 16,725 Lantern Pharma shares in Q3 2026, an estimated $69.7K.
Dimensional Fund Advisors first reported a position in Lantern Pharma in Q4 2023 and held it in 11 quarters.
Dimensional Fund Advisors's Lantern Pharma position peaked at $175K in Q3 2025.
8 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.